CA2026606A1 - Photographic developing solution for use with fore-hardened x-ray films - Google Patents
Photographic developing solution for use with fore-hardened x-ray filmsInfo
- Publication number
- CA2026606A1 CA2026606A1 CA 2026606 CA2026606A CA2026606A1 CA 2026606 A1 CA2026606 A1 CA 2026606A1 CA 2026606 CA2026606 CA 2026606 CA 2026606 A CA2026606 A CA 2026606A CA 2026606 A1 CA2026606 A1 CA 2026606A1
- Authority
- CA
- Canada
- Prior art keywords
- developing solution
- grams per
- per liter
- developing
- pyrazolidinone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 43
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000011161 development Methods 0.000 claims abstract description 14
- 239000003755 preservative agent Substances 0.000 claims abstract description 11
- -1 silver halide Chemical class 0.000 claims abstract description 11
- 239000000654 additive Substances 0.000 claims abstract description 10
- DSVIHYOAKPVFEH-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(CO)CN1C1=CC=CC=C1 DSVIHYOAKPVFEH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000002335 preservative effect Effects 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 229910052709 silver Inorganic materials 0.000 claims abstract description 6
- 239000004332 silver Substances 0.000 claims abstract description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 11
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 9
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical group C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 claims description 8
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 229960003330 pentetic acid Drugs 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 claims description 4
- 235000019252 potassium sulphite Nutrition 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical group 0.000 claims description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 3
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 3
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 3
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 2
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 claims 2
- 230000008569 process Effects 0.000 abstract description 11
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000009472 formulation Methods 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 36
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 7
- 238000004806 packaging method and process Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000012670 alkaline solution Substances 0.000 description 4
- CARFETJZUQORNQ-UHFFFAOYSA-N 1h-pyrrole-2-thiol Chemical compound SC1=CC=CN1 CARFETJZUQORNQ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 3
- 239000012964 benzotriazole Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000003352 sequestering agent Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 125000003396 thiol group Chemical group [H]S* 0.000 description 3
- CNHDIAIOKMXOLK-UHFFFAOYSA-N toluquinol Chemical compound CC1=CC(O)=CC=C1O CNHDIAIOKMXOLK-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- JAAIPIWKKXCNOC-UHFFFAOYSA-N 1h-tetrazol-1-ium-5-thiolate Chemical compound SC1=NN=NN1 JAAIPIWKKXCNOC-UHFFFAOYSA-N 0.000 description 2
- GRUVVLWKPGIYEG-UHFFFAOYSA-N 2-[2-[carboxymethyl-[(2-hydroxyphenyl)methyl]amino]ethyl-[(2-hydroxyphenyl)methyl]amino]acetic acid Chemical compound C=1C=CC=C(O)C=1CN(CC(=O)O)CCN(CC(O)=O)CC1=CC=CC=C1O GRUVVLWKPGIYEG-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 150000001565 benzotriazoles Chemical class 0.000 description 2
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- 150000004867 thiadiazoles Chemical group 0.000 description 2
- 150000003852 triazoles Chemical class 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- WZRRRFSJFQTGGB-UHFFFAOYSA-N 1,3,5-triazinane-2,4,6-trithione Chemical compound S=C1NC(=S)NC(=S)N1 WZRRRFSJFQTGGB-UHFFFAOYSA-N 0.000 description 1
- YHMYGUUIMTVXNW-UHFFFAOYSA-N 1,3-dihydrobenzimidazole-2-thione Chemical compound C1=CC=C2NC(S)=NC2=C1 YHMYGUUIMTVXNW-UHFFFAOYSA-N 0.000 description 1
- OXFSTTJBVAAALW-UHFFFAOYSA-N 1,3-dihydroimidazole-2-thione Chemical class SC1=NC=CN1 OXFSTTJBVAAALW-UHFFFAOYSA-N 0.000 description 1
- XIWRQEFBSZWJTH-UHFFFAOYSA-N 2,3-dibromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1Br XIWRQEFBSZWJTH-UHFFFAOYSA-N 0.000 description 1
- DBCKMJVEAUXWJJ-UHFFFAOYSA-N 2,3-dichlorobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Cl)=C1Cl DBCKMJVEAUXWJJ-UHFFFAOYSA-N 0.000 description 1
- YZDIUKPBJDYTOM-UHFFFAOYSA-N 2,5-diethylbenzene-1,4-diol Chemical compound CCC1=CC(O)=C(CC)C=C1O YZDIUKPBJDYTOM-UHFFFAOYSA-N 0.000 description 1
- GPASWZHHWPVSRG-UHFFFAOYSA-N 2,5-dimethylbenzene-1,4-diol Chemical compound CC1=CC(O)=C(C)C=C1O GPASWZHHWPVSRG-UHFFFAOYSA-N 0.000 description 1
- HIGSPBFIOSHWQG-UHFFFAOYSA-N 2-Isopropyl-1,4-benzenediol Chemical compound CC(C)C1=CC(O)=CC=C1O HIGSPBFIOSHWQG-UHFFFAOYSA-N 0.000 description 1
- XNCSCQSQSGDGES-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)C(C)CN(CC(O)=O)CC(O)=O XNCSCQSQSGDGES-UHFFFAOYSA-N 0.000 description 1
- DMQQXDPCRUGSQB-UHFFFAOYSA-N 2-[3-[bis(carboxymethyl)amino]propyl-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCCN(CC(O)=O)CC(O)=O DMQQXDPCRUGSQB-UHFFFAOYSA-N 0.000 description 1
- WYMDDFRYORANCC-UHFFFAOYSA-N 2-[[3-[bis(carboxymethyl)amino]-2-hydroxypropyl]-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)CN(CC(O)=O)CC(O)=O WYMDDFRYORANCC-UHFFFAOYSA-N 0.000 description 1
- REFDOIWRJDGBHY-UHFFFAOYSA-N 2-bromobenzene-1,4-diol Chemical compound OC1=CC=C(O)C(Br)=C1 REFDOIWRJDGBHY-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- QGTQPTZBBLHLBV-UHFFFAOYSA-N 3,4-diphenyl-1h-1,2,4-triazole-5-thione Chemical compound C=1C=CC=CC=1N1C(=S)NN=C1C1=CC=CC=C1 QGTQPTZBBLHLBV-UHFFFAOYSA-N 0.000 description 1
- AJKLCDRWGVLVSH-UHFFFAOYSA-N 4,4-bis(hydroxymethyl)-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CO)(CO)CN1C1=CC=CC=C1 AJKLCDRWGVLVSH-UHFFFAOYSA-N 0.000 description 1
- WVFKEYZGOJNZBS-UHFFFAOYSA-N 4,4-diethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CC)(CC)CN1C1=CC=CC=C1 WVFKEYZGOJNZBS-UHFFFAOYSA-N 0.000 description 1
- SJSJAWHHGDPBOC-UHFFFAOYSA-N 4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=CC=C1 SJSJAWHHGDPBOC-UHFFFAOYSA-N 0.000 description 1
- DNJANJSHTMOQOV-UHFFFAOYSA-N 4-bromo-2h-benzotriazole Chemical compound BrC1=CC=CC2=C1N=NN2 DNJANJSHTMOQOV-UHFFFAOYSA-N 0.000 description 1
- NGKNMHFWZMHABQ-UHFFFAOYSA-N 4-chloro-2h-benzotriazole Chemical compound ClC1=CC=CC2=NNN=C12 NGKNMHFWZMHABQ-UHFFFAOYSA-N 0.000 description 1
- IXLQFFRXRKDIRN-UHFFFAOYSA-N 4-ethyl-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CC)(C)CN1C1=CC=CC=C1 IXLQFFRXRKDIRN-UHFFFAOYSA-N 0.000 description 1
- ISOLPDRTYOTMTO-UHFFFAOYSA-N 4-phenyl-1,3-dihydroimidazole-2-thione Chemical compound N1C(S)=NC(C=2C=CC=CC=2)=C1 ISOLPDRTYOTMTO-UHFFFAOYSA-N 0.000 description 1
- XCEAATBVFYNDLR-UHFFFAOYSA-N 5-(2-methylphenyl)-3h-1,3,4-thiadiazole-2-thione Chemical compound CC1=CC=CC=C1C1=NN=C(S)S1 XCEAATBVFYNDLR-UHFFFAOYSA-N 0.000 description 1
- PZBQVZFITSVHAW-UHFFFAOYSA-N 5-chloro-2h-benzotriazole Chemical compound C1=C(Cl)C=CC2=NNN=C21 PZBQVZFITSVHAW-UHFFFAOYSA-N 0.000 description 1
- OUZCWDMJTKYHCA-UHFFFAOYSA-N 5-methyl-1h-1,2,4-triazol-1-ium-3-thiolate Chemical compound CC1=NNC(S)=N1 OUZCWDMJTKYHCA-UHFFFAOYSA-N 0.000 description 1
- FOHWXVBZGSVUGO-UHFFFAOYSA-N 5-phenyl-3h-1,3,4-oxadiazole-2-thione Chemical compound O1C(S)=NN=C1C1=CC=CC=C1 FOHWXVBZGSVUGO-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 101000618467 Hypocrea jecorina (strain ATCC 56765 / BCRC 32924 / NRRL 11460 / Rut C-30) Endo-1,4-beta-xylanase 2 Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001513 alkali metal bromide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- JINBYESILADKFW-UHFFFAOYSA-N aminomalonic acid Chemical compound OC(=O)C(N)C(O)=O JINBYESILADKFW-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 150000001768 cations Chemical group 0.000 description 1
- AJPXTSMULZANCB-UHFFFAOYSA-N chlorohydroquinone Chemical compound OC1=CC=C(O)C(Cl)=C1 AJPXTSMULZANCB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- BBLSYMNDKUHQAG-UHFFFAOYSA-L dilithium;sulfite Chemical compound [Li+].[Li+].[O-]S([O-])=O BBLSYMNDKUHQAG-UHFFFAOYSA-L 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- SRPOMGSPELCIGZ-UHFFFAOYSA-N disulfino carbonate Chemical class OS(=O)OC(=O)OS(O)=O SRPOMGSPELCIGZ-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N hydroquinone methyl ether Natural products COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- DFNPYGYKBYCQSV-UHFFFAOYSA-N n-(4-acetamido-2,5-dihydroxyphenyl)acetamide Chemical compound CC(=O)NC1=CC(O)=C(NC(C)=O)C=C1O DFNPYGYKBYCQSV-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- 239000000837 restrainer Substances 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- UOULCEYHQNCFFH-UHFFFAOYSA-M sodium;hydroxymethanesulfonate Chemical compound [Na+].OCS([O-])(=O)=O UOULCEYHQNCFFH-UHFFFAOYSA-M 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 150000003567 thiocyanates Chemical class 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
- 229950000329 thiouracil Drugs 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 229940086542 triethylamine Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/30—Developers
- G03C5/3028—Heterocyclic compounds
- G03C5/3035—Heterocyclic compounds containing a diazole ring
Landscapes
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
PHOTOGRAPHIC DEVELOPING SOLUTION FOR
USE WITH FORE-HARDENED X-RAY FILMS
Abstract of the Disclosure An aqueous alkaline photographic developing solution that is especially adapted for use in the development of fore-hardened X-ray films has a pH in the range of 9 to 12, is substantially free of both aldehydic hardening agents and silver halide solvents, and comprises (1) a dihydroxybenzene developing agent, such as hydroquinone, (2) at least 3.5 grams per liter of developing solution of a 4,4-disubstituted-1-aryl-3-pyrazolidinone, which functions as an auxiliary super-additive developing agent, such as 4-hydroxy-methyl-4-methyl-1-phenyl-3-pyrazolidinone, (3) an alkaline agent, (4) an organic antifoggant, and (5) a preservative. The developing solution is capable of being packaged as a single part formulation and provides a very short process time and excellent sensitometric results.
USE WITH FORE-HARDENED X-RAY FILMS
Abstract of the Disclosure An aqueous alkaline photographic developing solution that is especially adapted for use in the development of fore-hardened X-ray films has a pH in the range of 9 to 12, is substantially free of both aldehydic hardening agents and silver halide solvents, and comprises (1) a dihydroxybenzene developing agent, such as hydroquinone, (2) at least 3.5 grams per liter of developing solution of a 4,4-disubstituted-1-aryl-3-pyrazolidinone, which functions as an auxiliary super-additive developing agent, such as 4-hydroxy-methyl-4-methyl-1-phenyl-3-pyrazolidinone, (3) an alkaline agent, (4) an organic antifoggant, and (5) a preservative. The developing solution is capable of being packaged as a single part formulation and provides a very short process time and excellent sensitometric results.
Description
~ 2026606 PHOTOGRAPHIC DEVELOPING SOLUTION FOR
USE WITH FORE-HARDENED X-RAY FILMS
Field Qf the Invention This invention relates in ~eneral to photography and in particular to the development of X-ray films. More specifically, this invention relates to an improved aqueous alkaline photographic developing solu~ion that i8 especially adapted for use in the development of fore-hardened X-ray films.
Background of the Invention Heretofore, developing solutions for use with X-ray film have typically been formulated using hydro~uinone as the primary developing agent, l-phenyl-3-pyrazolidinone as a super-additive auxiliary developing agent and glutaraldehyde as a hardening agent. These developing solutions have been packaged as three-part formulations. The need for the added cost and complexity of three-part packaging has been dictated by the fact that glutaraldehyde tends to react with 1-phenyl-3-pyrazolidinone, that l-phenyl-3-pyrazolidinone tends to oxidize in alkaline solution, and that glutaraldehyde tendi to polymerize in alkaline solution. To avoid these problems, the hydroquinone has been packaged in a first part which is alkaline, the 1-phenyl-3-pyrazolidinone has been packaged in a second part which is acidic, and the glutaraldehyde has been packaged in a third part which is acidic. Prior to use, the three parts are blended together and diluted with water to give the appropriate concentration and alkaline pH for use as a working developing solution. Representative of the prior art relating to developing solutions for use with X-ray films are U. S. Patents 3,545,971, - 4,046,571, 4,672,025 and 4,810,622, all of which 3S describe developing solutions that contain aldehydic hardening agents, such as glutaraldehyde, and are packaged as three-part formulations. Aldehydic g; ~
2026~06 hardenin~ agents are not needed in developing solutions intended for uæe in processing X-ray films which have been adequately fore-hardened, such as those described in U. S. Patent 4,414,304. The fore-hardened tabular grain emulsions of Patent '304 offer the advantage of exhibiting high levels of covering power that are relatively insenæitive to increasing levels of fore-hardening. At the same time, by reason of being fore-hardened, the radiographic elements of Patent '304 ingest less water during processing and therefore lend themselves to ~-accelerated processing, typically to total processing times of 45 seconds or less. It is essential, however, to be able to prccess such fore-hardened films in a process that provides a very short process time without sacrificing the equally important requirement of achieving proper sensitometry. A
specific aim is to match the sensitometry of - -~
conventional radiographic products now processed in aldehydic developers, such as that of the standard 90 second Kodak RP X~OmatTM process. It is also highly advantageous to be able to avoid complex multi-part -packaging and achieve the convenience of one-part packaging without compromising the performance of the developing solution.
It is toward the objective of providing an improved developing solution that is especially adapted for processing fore-hardened X-ray films, that -is capable of providing a very short process time, that is capable of producing sensitometric responses similar to those achieved with conventional aldehydic developers, and that exhibits the convenience and simplicity of one-part packaging and excellent sensitometry, that the present invention is directed.
SUMMARY OF T~E INVENTION
It has now been found, most unexpectedly, that by using a 4,4-disubstituted-1-aryl-3-pyrazoli-dinone in an amount of.at least 3.5 grams per liter of developing solution as the auxiliary super-additive developing agent, it is feasibl~ to formulate the developing solution in a single part and, at the same time, achieve a very short process time while meeting all sensitometric requirements that are important for X-ray film development. Thus, the present invention provides an aqueous alkaline developing æolution that is especially adapted for use in the development of fore-hardened X-ray films; the developing solution having a pH in the range of 9 to 12, being substan-tially free of both aldehydic hardening agents and silver halide solvents, and comprising a dihydroxy-benzene developing agent, such as hydroquinone, an auxiliary super-additive developing agent that is a 4,4-disubstituted-1-aryl3-pyrazolidinone in an amount of at least two grams per liter of developing solution, an alkaline agent, an organic antifoggant, and a preservative. The 4,4-disubstituted-l-aryl-3-pyrazolidinone is of the formula:
R
O= C--C/
¦ \R2 ~ 2 0\- ~ R3 wherein Rl and R2 are the same or different and each is alkyl of 1 to 6 carbon atoms or hydroxyalkyl of 1 to 6 carbon atoms, and R3 is hydrogen, halogen, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carb~n atoms.
In the present invention, no problem is encountered in packaging the 4,4 disubstituted-l-aryl-3-pyrazolidinone in an alkaline solution since æuch subætituted pyrazolidinones are resistant to oxidation in alkaline solution. Use of this compound in the required amount of at least 3.5 grams per liter of developing solution provides the desired characteristics of very short process time with excellent sensitometry.
Description Qf Preferred Embodiments The developing solution of this invention is free, or at least substantially free, o~ aldehydic hardening agents such as glutaraldehyde. Since the developing solution is intended for use with X-ray films that have been adequately fore-hardened, the incorporation of hardening agents in the developing solution is unnecessary.
The developing solution of this invention is free, or at least substantially free, of silver halide solvents, such as thiosulfates or thiocyanates, as these solvents are detrimental to its performance in development of fore-hardened X-ray films and would -;
provide unacceptable sensitometry.
The dihydroxybenzene developing agentis employed in the aqueous alkaline teveloping solutions of this invention are well known and widely used in photographic processing. The preferred developing agent of this class ii3 hydroquinone. Other useful dihydroxybenzene developing agents include:
chlorohydroquinone, bromohydroquinone, isopropylhydroquinone, toluhydroquinone, methylhydroquinone, 2,3-dichlorohydroquinone, 2,5-dimethylhydroquinone, 2,3-dibromohydroquinone, 1,4-dihydroxy-2-aeetophenone-2,5-dimethylhydro-quinone, 2,5-diethylhydroquinone, 2,5-di-p-phenethylhydroquinone, , ' ' ' ; ' ;",' ~
~i ''' ' ' '. . " ;~ ' ' "'., ", " ' ' :
-`` 20~6~6 ~5--2,5-dibenzoylaminohydroquinone, 2,5-diacetaminohydroquinone, and the like.
In addition to the dihydroxybenzene developing agent, the developing solution must include a 4,4-disubstituted-1-aryl-3-pyrazolidinone, of the structure indicated hereinabove, which functions as an auxiliary super-additive developing agent. Specific examples of the 4,4-disubstituted-1-aryl-3-pyrazoli-dinone developing agents include:
4,4-dimethyl-1-phenyl-3-pyrazolidinone, 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone (HMMP~, 4,4-di-(hydroxymethyl)-1-phenyl-3-pyrazolidinone, 4,4-diethyl-1-phenyl-3-pyrazolidinone, 4-methyl-4-ethyl-1-phenyl-3-pyrazolidinone, and the like.
Suitable alkaline agents which can be included in the developing solution to maintain the desired alkaline pH include hydroxides such as sodium hydroxide or potassium hydroxide, bicarbonates such as sodium bicarbonate or potassium bicarbonate, and borates such as sodium tetraborate.
To minimize problems of fo~ formation, an effective amount of an organic antifoggant is included in the developing solution of this invention.
Particularly advantageous results are achieved with the use of benzotriazole antifoggants.
A further preferred class of organic antifoggants are the mercapto azole antifoggants. Inorganic antifoggants or restrainers, such as alkali metal bromides, can be utilized in conjunction with the use of an organic antifoggant, if desired.
Particularly preferred benzotriazole antifoggants for use in the developing solutions of this invention are benzotriazole, halo-substituted benzotriazoles such as 4-chlorobenzotriazole;
, .. .. : ~ , ^` 2~26606 4-bromobenzotriazole and 5-chlorobenzotriazole, and alkyl-substituted benzotriazoles such as 5-methyl-benzotriazole.
Preferred mercapto azole antifoggants are those represented by the formula:
~ZXC (SX)n wherein Z represents the atomR necessary to complete a 5 or 6 member heterocyclic ring, such as pyrimidine, triazine, tetrazole, triazole, imidazole, diazole, n oxadiazole or thiadiazole ring; and SX represeDts a mercapto function, n being a whole number, typically a number from 1 to about 3, any free bonds being -satisfied by hydrogen atoms. In the mercapto function or group, X is a cation which includes hydrogen, an alkali metal, e.g., sodium or potassium, ammonium or an organic amine residue of such amines as triethyl amine, triethanolamine, morpholine and the like.
Mercapto tetrazole antifoggants are especially suitable in the practice of this invention and include those of the formula:
~ ~ -R
C
SX .... -.-wherein R is an aliphatic or aromatic radical containing up to about 30 carbon atoms and SX is a ~mercapto function.
,, Specific examples of mercapto azole antifoggants include:
mercapto-substituted pyrimidines such as thiobar-bituric acid and thiouracil, mercapto-substituted oxadiazoles or thiadiazoles such as 5-phenyl-2-mercapto-1,3,4-oxadiazole and 5-o-tolyl-2-mercapto-1,3,4-thiadiazole, mercap~o triazines æuch as 2,4,6-trimercapto-1,3,5-triazine, mercapto imidazoles æuch as 2-mercapto-5-phenyl-imidazole, condensed imidazoles such as 2-mercaptobenz-imidazole, triazoles such as 3,4-diphenyl-5-mercapto-1,2,4-triazole and 3-mercapto-5-methyl-1,2,4-triazole, mercapto tetrazoles such as l-phenyl-5-mercapto-tetrazole and 1-(3-capramido)phenyl-5-mercapto-tetrazole.
The aqueous alkaline photographic developing solutions of this invention preferably contain a sulfite preservative at a level sufficient to protect the developing agents against aerial oxidation and thereby promote good stability characteristics.
Useful sulfite preservatives include sulfites, bisulfites, metabisulfites, and carbonyl bisulfite adducts. Typical examples of sulfite preservatives include:
sodium sulfite, potassium sulfite, lithium sulfite, ammonium sulfite, sodium bisulfitef potassium metabisulfite, sodium formaldehyde bisulfite, and the like.
Other preservatives such as hydroxylamine and ascorbic acid can be used instead of or in combination with the sulfites.
In addition to the primary developing agent, auxiliary developing agent, alkaline agent, organic antifoggant and preservative, the aqueous alkaline photographic developing solution of this invention can optionally contain other ingredients including sequestering agents, surfactants, and organic solvents ~` 2026606 such as diethylene glycol.
The aminopolycarboxylic acid sequestering agents are particularly useful in the developing solutions of this invention. Typical examples of the aminopolycarboxylic acid sequestering agents include:
nitrilotriacetic acid, (NTA), ethylenediaminetetraacetic acid, (EDTA~, 1,3-propylenediaminetetraacetic acid (PDTA), 1-3-diamino-2-propanol-N,N,N',N'-tetraacetic acid (DPTA), diethylenetriaminepentaacetic acid (DTPA), N,N'-bis(2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid (HBED), hydroxyethylenediaminetriacetic acid, cyclohexanediaminotetraacetic acid, aminomalonic acid, and the like.
The aqueous alkaline developing solutions of this invention can vary widely in regard to the concentration of the various ingredients included therein. Typically, the dihydroxybenzene developing agent is used in an amount of from about 20 to about 60 grams per liter, the 4,4-disubstituted-1-aryl-3-pyrazolidinone is used in an amount of greater than 3 grams per liter, more preferably in an amount of 3.5 to 10 grams per liter and most preferably in an amount of 4 to 8 grams per liter, the alkaline agent i8 used ; in an amount of about 10 to about 50 grams per liter,the organic antifoggant is used in an amount of about 0.1 to about 0.5 grams per liter, and the preservative is used in an amount of about 20 to about 100 grams per liter. The pH of the developing æolution is in the range of from 9 to 12 and more preferably in the range of from 9.5 to 11.
The developing process is typically carried out at a temperature of about 25C to about 50C.
With the developing solution of this invention, very 2026~06 short developing timesi such as times of 10 seconds, or less, are feasible, with total processing times of 45 seconds or less being contemplated. For example, fore-hardened radiographic elements when processed in the following 45 second cycle using the developer of this invention can produce sensitometric character-istics matching those obtained with conventional radiographic products processed in a 90 second cycle using an aldehydic developer:
development 10.2 sec. 35C
fixing 8.7 sec. 35C
washing 7.2 sec. 35C
drying 17.0 sec. 65C
Time otherwise unaccounted for is used for film transport.
A particularly preferred aqueous alkaline photographic developing solution within the scope of this invention is a solution consisting essentially of 25 to 50 grams per liter of hydroquinone, 4 to 8 grams per liter of 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone, 5 to 10 grams per liter of sodium bicarbonate, 20 to 40 grams per liter of potassium hydroxide, 0.1 to 0.3 grams per liter of 5-methyl-benzotriazole, 50 to 80 grams per liter of potassium sulfite, 5 to 10 grams per liter of sodium metabisulfite, 1 to 4 grams per liter of æodium bromide, 10 to 30 grams per liter of diethylene glycol and 2 to 4 grams per liter of diethylenetriaminepenta-acetic acid.
The in~ention is further illustrated by the following examples of its practice.
~xamples 1-4 Aqueous alkaline photographic developing solutions were prepared in accordance with the following formulations:
l , ~ ,, -, .. , .: / . . . .
-- 20~6606 TabLe-l ~,m~lnt (gr~ms ?
Ingredient EX 1 EX 2 EX 3 EX 4 Sodium metabisulfite 8.0 8.85 8.85 8.85 Potassium hydroxide (45Z solution)60.0 50.0 57.8 60.0 Diethylenetriamine-pentaacetic acid (40% solution)7.1 7.1 7.1 7.1 Sodium bromide 2.25 2.25 2.25 2.25 Sodium bicarbonate7.5 7.5 7.5 7.5 Potassium sulfite (45% solution)119.3 159.0 159.0 159.0 4-Hydroxymethyl-4-methyl-l-phenyl-3-pyrazolidinone3.5 5.0 4.51 3.67 5-Methylbenzotriazole 0.12 0.12 0.151 0.119 Diethylene glycol20.0 20.0 20.0 20.0 Hydroquinone 39.0 32.0 34.2 51.3 Water to one liter pH at 25C 10.7 10.5 10.83 10.71 The above-described developing solutions were each employed at a temperature of 35C to develop a fore-hardened X-ray film as described in U. S. patent 4,414,304. Development was completed in 10.2 seconds in each of Examples 1 and 2, in 9.2 seconds in Example 3 and in 7.8 seconds in Example 4. The total processing cycle time was 45 seconds for Examples 1 and 2, 40 seconds for Example 3, and 35 8econds for Example 4. Measurements were made with respect to gross fog, film speed at a density of 1.0 above gross fog (l.OCR), mid scale contrast (MSC), lower scale contrast (LSC), upper scale contrast (USC~, and upper density point (UDP) and were found, in each case, to be acceptably similar to those obtained in the standard KODAK RP X-OMATTM proce~s. Each of the developing solutions was capable of being formulated ~ 2026606 and packaged as a single-part composition which exhibited acceptable shelf life and stability.
Example 5 In thiæ Example the sensitometric per~ormance obtained using the processing of Example 2 and three controls 2-A, 2-B and 2-C, differing from the Example 2 solely by the level of HMMP present, were compared with the sensitometric performance of a radiographic product intended to be processed in an aldehydic developer, such as a Kodak RP X-OmatTM 90 second process. Specifically, in Table II below the RP
X-Omat performance indicates the performance of a radiographic element of the type described in U.S.
Patent 4,900,652 processed in the following cycle:
development 24 sec. 35C
fixing 20 sec. 35C
washing 10 sec. 35C
drying 20 sec. 65C
Total processing time being 90 seconds, with time not otherwise accounted for being used in film transport.
The developer exhibited the following composition:
Hydroquinone 22 g l-Phenyl-3-pyrazolidone 1.35 g KOH 19.23 g NaHCO3 5.81 g K2S03 75 g NaBr 3.5 g 5-Methylbenzotriazole 0.06 g Glutaraldehyde 4.44 g 30, Water to 1 liter at pH 10.1 In addition another developer having a still higher HMMP level than that of Example 2 was compared. This developer, referred to the Example 5 developer, had the following composition:
Eydroquinone 32 g ~MMP 6 g KOH 24.4 g 5 NaHC03 7.5 g 2S3 75 g NaBr 2.25 g 5-Methylbenzotriazole 0.12 Water to 1 liter at pE 10.35.
A radiographic element identical to that employed in Example 2 was processed in the Example 5 developer using the following 45 æecond process cycle:
development 10.2 sec. 35C
fixing 8.7 sec. 35OC
washing 7.2 sec. 35C
drying 17.0 sec. 65C
Time not otherwise accounted for was consumed in film transport.
The results are compared below in Table II.
Table II ~`
Concentration ~ -Test of HMMP Gross Film (eramslliter) EQ~ Speed MSC LSC _~S UDP
2-A (Gomp.) 0.5 0.20 416 3.20 2.26 2.70 3.70 - :
2-B (Comp.) 1.0 0.20 424 3.24 2.20 3.05 3.75 25 2-C (Comp.) 3.0 0.21 433 2.94 2.09 2.66 3.59 Ex. 2 5.0 0.21 437 2.81 2.02 2.60 3.57 RP X-Omat 1.5* 0.20 438 2.89 2.00 3.34 3.65 Ex;. 5 6.0 0.22 439 2.91 2.05 3.07 3.70 *l-Phenyl-3-pryazolidone The data reported in Table II indicate that the developers of Examples 2 and 5 produced ; sensitometric resultæ cloæely approximating those obtained with the RP X-Omat 90 second procesæ in terms of speed, lower æcale contrast (LSC) and middle scale contrast (MSC). Theæe æenæitometric parameteræ affect the lower denæity image regions to which the eye is particularly senæitive. While some divergence in '.!,~,3, ~
~ 202~606 upper scale contrast (USC) and upper density point ~UDP) were observed, the eye is much less sensitive to variances in upper density image regions; therefore, these variances were deemed acceptable.
Comparing the performance of Controls 2-A, 2-B and 2-C, it can be seen that lower levels of EMMP
in these developers resulted in relatively poor matches in speed, MSC and LSC. Specifically, speeds were lower than those produced by RP X-Omat 90 second process and lower and middle scale contrasts were both elevated, indicating the importance of employing higher levels of ~MMP in the aldehydic hardener free developers of the invention.
The invention has been described in detail with particular reference to preferred embodiments thereof, but it will be understood that variations and modifications can be effected within the spirit and scope of the invention.
~ ~`
' ~' ~ -
USE WITH FORE-HARDENED X-RAY FILMS
Field Qf the Invention This invention relates in ~eneral to photography and in particular to the development of X-ray films. More specifically, this invention relates to an improved aqueous alkaline photographic developing solu~ion that i8 especially adapted for use in the development of fore-hardened X-ray films.
Background of the Invention Heretofore, developing solutions for use with X-ray film have typically been formulated using hydro~uinone as the primary developing agent, l-phenyl-3-pyrazolidinone as a super-additive auxiliary developing agent and glutaraldehyde as a hardening agent. These developing solutions have been packaged as three-part formulations. The need for the added cost and complexity of three-part packaging has been dictated by the fact that glutaraldehyde tends to react with 1-phenyl-3-pyrazolidinone, that l-phenyl-3-pyrazolidinone tends to oxidize in alkaline solution, and that glutaraldehyde tendi to polymerize in alkaline solution. To avoid these problems, the hydroquinone has been packaged in a first part which is alkaline, the 1-phenyl-3-pyrazolidinone has been packaged in a second part which is acidic, and the glutaraldehyde has been packaged in a third part which is acidic. Prior to use, the three parts are blended together and diluted with water to give the appropriate concentration and alkaline pH for use as a working developing solution. Representative of the prior art relating to developing solutions for use with X-ray films are U. S. Patents 3,545,971, - 4,046,571, 4,672,025 and 4,810,622, all of which 3S describe developing solutions that contain aldehydic hardening agents, such as glutaraldehyde, and are packaged as three-part formulations. Aldehydic g; ~
2026~06 hardenin~ agents are not needed in developing solutions intended for uæe in processing X-ray films which have been adequately fore-hardened, such as those described in U. S. Patent 4,414,304. The fore-hardened tabular grain emulsions of Patent '304 offer the advantage of exhibiting high levels of covering power that are relatively insenæitive to increasing levels of fore-hardening. At the same time, by reason of being fore-hardened, the radiographic elements of Patent '304 ingest less water during processing and therefore lend themselves to ~-accelerated processing, typically to total processing times of 45 seconds or less. It is essential, however, to be able to prccess such fore-hardened films in a process that provides a very short process time without sacrificing the equally important requirement of achieving proper sensitometry. A
specific aim is to match the sensitometry of - -~
conventional radiographic products now processed in aldehydic developers, such as that of the standard 90 second Kodak RP X~OmatTM process. It is also highly advantageous to be able to avoid complex multi-part -packaging and achieve the convenience of one-part packaging without compromising the performance of the developing solution.
It is toward the objective of providing an improved developing solution that is especially adapted for processing fore-hardened X-ray films, that -is capable of providing a very short process time, that is capable of producing sensitometric responses similar to those achieved with conventional aldehydic developers, and that exhibits the convenience and simplicity of one-part packaging and excellent sensitometry, that the present invention is directed.
SUMMARY OF T~E INVENTION
It has now been found, most unexpectedly, that by using a 4,4-disubstituted-1-aryl-3-pyrazoli-dinone in an amount of.at least 3.5 grams per liter of developing solution as the auxiliary super-additive developing agent, it is feasibl~ to formulate the developing solution in a single part and, at the same time, achieve a very short process time while meeting all sensitometric requirements that are important for X-ray film development. Thus, the present invention provides an aqueous alkaline developing æolution that is especially adapted for use in the development of fore-hardened X-ray films; the developing solution having a pH in the range of 9 to 12, being substan-tially free of both aldehydic hardening agents and silver halide solvents, and comprising a dihydroxy-benzene developing agent, such as hydroquinone, an auxiliary super-additive developing agent that is a 4,4-disubstituted-1-aryl3-pyrazolidinone in an amount of at least two grams per liter of developing solution, an alkaline agent, an organic antifoggant, and a preservative. The 4,4-disubstituted-l-aryl-3-pyrazolidinone is of the formula:
R
O= C--C/
¦ \R2 ~ 2 0\- ~ R3 wherein Rl and R2 are the same or different and each is alkyl of 1 to 6 carbon atoms or hydroxyalkyl of 1 to 6 carbon atoms, and R3 is hydrogen, halogen, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carb~n atoms.
In the present invention, no problem is encountered in packaging the 4,4 disubstituted-l-aryl-3-pyrazolidinone in an alkaline solution since æuch subætituted pyrazolidinones are resistant to oxidation in alkaline solution. Use of this compound in the required amount of at least 3.5 grams per liter of developing solution provides the desired characteristics of very short process time with excellent sensitometry.
Description Qf Preferred Embodiments The developing solution of this invention is free, or at least substantially free, o~ aldehydic hardening agents such as glutaraldehyde. Since the developing solution is intended for use with X-ray films that have been adequately fore-hardened, the incorporation of hardening agents in the developing solution is unnecessary.
The developing solution of this invention is free, or at least substantially free, of silver halide solvents, such as thiosulfates or thiocyanates, as these solvents are detrimental to its performance in development of fore-hardened X-ray films and would -;
provide unacceptable sensitometry.
The dihydroxybenzene developing agentis employed in the aqueous alkaline teveloping solutions of this invention are well known and widely used in photographic processing. The preferred developing agent of this class ii3 hydroquinone. Other useful dihydroxybenzene developing agents include:
chlorohydroquinone, bromohydroquinone, isopropylhydroquinone, toluhydroquinone, methylhydroquinone, 2,3-dichlorohydroquinone, 2,5-dimethylhydroquinone, 2,3-dibromohydroquinone, 1,4-dihydroxy-2-aeetophenone-2,5-dimethylhydro-quinone, 2,5-diethylhydroquinone, 2,5-di-p-phenethylhydroquinone, , ' ' ' ; ' ;",' ~
~i ''' ' ' '. . " ;~ ' ' "'., ", " ' ' :
-`` 20~6~6 ~5--2,5-dibenzoylaminohydroquinone, 2,5-diacetaminohydroquinone, and the like.
In addition to the dihydroxybenzene developing agent, the developing solution must include a 4,4-disubstituted-1-aryl-3-pyrazolidinone, of the structure indicated hereinabove, which functions as an auxiliary super-additive developing agent. Specific examples of the 4,4-disubstituted-1-aryl-3-pyrazoli-dinone developing agents include:
4,4-dimethyl-1-phenyl-3-pyrazolidinone, 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone (HMMP~, 4,4-di-(hydroxymethyl)-1-phenyl-3-pyrazolidinone, 4,4-diethyl-1-phenyl-3-pyrazolidinone, 4-methyl-4-ethyl-1-phenyl-3-pyrazolidinone, and the like.
Suitable alkaline agents which can be included in the developing solution to maintain the desired alkaline pH include hydroxides such as sodium hydroxide or potassium hydroxide, bicarbonates such as sodium bicarbonate or potassium bicarbonate, and borates such as sodium tetraborate.
To minimize problems of fo~ formation, an effective amount of an organic antifoggant is included in the developing solution of this invention.
Particularly advantageous results are achieved with the use of benzotriazole antifoggants.
A further preferred class of organic antifoggants are the mercapto azole antifoggants. Inorganic antifoggants or restrainers, such as alkali metal bromides, can be utilized in conjunction with the use of an organic antifoggant, if desired.
Particularly preferred benzotriazole antifoggants for use in the developing solutions of this invention are benzotriazole, halo-substituted benzotriazoles such as 4-chlorobenzotriazole;
, .. .. : ~ , ^` 2~26606 4-bromobenzotriazole and 5-chlorobenzotriazole, and alkyl-substituted benzotriazoles such as 5-methyl-benzotriazole.
Preferred mercapto azole antifoggants are those represented by the formula:
~ZXC (SX)n wherein Z represents the atomR necessary to complete a 5 or 6 member heterocyclic ring, such as pyrimidine, triazine, tetrazole, triazole, imidazole, diazole, n oxadiazole or thiadiazole ring; and SX represeDts a mercapto function, n being a whole number, typically a number from 1 to about 3, any free bonds being -satisfied by hydrogen atoms. In the mercapto function or group, X is a cation which includes hydrogen, an alkali metal, e.g., sodium or potassium, ammonium or an organic amine residue of such amines as triethyl amine, triethanolamine, morpholine and the like.
Mercapto tetrazole antifoggants are especially suitable in the practice of this invention and include those of the formula:
~ ~ -R
C
SX .... -.-wherein R is an aliphatic or aromatic radical containing up to about 30 carbon atoms and SX is a ~mercapto function.
,, Specific examples of mercapto azole antifoggants include:
mercapto-substituted pyrimidines such as thiobar-bituric acid and thiouracil, mercapto-substituted oxadiazoles or thiadiazoles such as 5-phenyl-2-mercapto-1,3,4-oxadiazole and 5-o-tolyl-2-mercapto-1,3,4-thiadiazole, mercap~o triazines æuch as 2,4,6-trimercapto-1,3,5-triazine, mercapto imidazoles æuch as 2-mercapto-5-phenyl-imidazole, condensed imidazoles such as 2-mercaptobenz-imidazole, triazoles such as 3,4-diphenyl-5-mercapto-1,2,4-triazole and 3-mercapto-5-methyl-1,2,4-triazole, mercapto tetrazoles such as l-phenyl-5-mercapto-tetrazole and 1-(3-capramido)phenyl-5-mercapto-tetrazole.
The aqueous alkaline photographic developing solutions of this invention preferably contain a sulfite preservative at a level sufficient to protect the developing agents against aerial oxidation and thereby promote good stability characteristics.
Useful sulfite preservatives include sulfites, bisulfites, metabisulfites, and carbonyl bisulfite adducts. Typical examples of sulfite preservatives include:
sodium sulfite, potassium sulfite, lithium sulfite, ammonium sulfite, sodium bisulfitef potassium metabisulfite, sodium formaldehyde bisulfite, and the like.
Other preservatives such as hydroxylamine and ascorbic acid can be used instead of or in combination with the sulfites.
In addition to the primary developing agent, auxiliary developing agent, alkaline agent, organic antifoggant and preservative, the aqueous alkaline photographic developing solution of this invention can optionally contain other ingredients including sequestering agents, surfactants, and organic solvents ~` 2026606 such as diethylene glycol.
The aminopolycarboxylic acid sequestering agents are particularly useful in the developing solutions of this invention. Typical examples of the aminopolycarboxylic acid sequestering agents include:
nitrilotriacetic acid, (NTA), ethylenediaminetetraacetic acid, (EDTA~, 1,3-propylenediaminetetraacetic acid (PDTA), 1-3-diamino-2-propanol-N,N,N',N'-tetraacetic acid (DPTA), diethylenetriaminepentaacetic acid (DTPA), N,N'-bis(2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid (HBED), hydroxyethylenediaminetriacetic acid, cyclohexanediaminotetraacetic acid, aminomalonic acid, and the like.
The aqueous alkaline developing solutions of this invention can vary widely in regard to the concentration of the various ingredients included therein. Typically, the dihydroxybenzene developing agent is used in an amount of from about 20 to about 60 grams per liter, the 4,4-disubstituted-1-aryl-3-pyrazolidinone is used in an amount of greater than 3 grams per liter, more preferably in an amount of 3.5 to 10 grams per liter and most preferably in an amount of 4 to 8 grams per liter, the alkaline agent i8 used ; in an amount of about 10 to about 50 grams per liter,the organic antifoggant is used in an amount of about 0.1 to about 0.5 grams per liter, and the preservative is used in an amount of about 20 to about 100 grams per liter. The pH of the developing æolution is in the range of from 9 to 12 and more preferably in the range of from 9.5 to 11.
The developing process is typically carried out at a temperature of about 25C to about 50C.
With the developing solution of this invention, very 2026~06 short developing timesi such as times of 10 seconds, or less, are feasible, with total processing times of 45 seconds or less being contemplated. For example, fore-hardened radiographic elements when processed in the following 45 second cycle using the developer of this invention can produce sensitometric character-istics matching those obtained with conventional radiographic products processed in a 90 second cycle using an aldehydic developer:
development 10.2 sec. 35C
fixing 8.7 sec. 35C
washing 7.2 sec. 35C
drying 17.0 sec. 65C
Time otherwise unaccounted for is used for film transport.
A particularly preferred aqueous alkaline photographic developing solution within the scope of this invention is a solution consisting essentially of 25 to 50 grams per liter of hydroquinone, 4 to 8 grams per liter of 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone, 5 to 10 grams per liter of sodium bicarbonate, 20 to 40 grams per liter of potassium hydroxide, 0.1 to 0.3 grams per liter of 5-methyl-benzotriazole, 50 to 80 grams per liter of potassium sulfite, 5 to 10 grams per liter of sodium metabisulfite, 1 to 4 grams per liter of æodium bromide, 10 to 30 grams per liter of diethylene glycol and 2 to 4 grams per liter of diethylenetriaminepenta-acetic acid.
The in~ention is further illustrated by the following examples of its practice.
~xamples 1-4 Aqueous alkaline photographic developing solutions were prepared in accordance with the following formulations:
l , ~ ,, -, .. , .: / . . . .
-- 20~6606 TabLe-l ~,m~lnt (gr~ms ?
Ingredient EX 1 EX 2 EX 3 EX 4 Sodium metabisulfite 8.0 8.85 8.85 8.85 Potassium hydroxide (45Z solution)60.0 50.0 57.8 60.0 Diethylenetriamine-pentaacetic acid (40% solution)7.1 7.1 7.1 7.1 Sodium bromide 2.25 2.25 2.25 2.25 Sodium bicarbonate7.5 7.5 7.5 7.5 Potassium sulfite (45% solution)119.3 159.0 159.0 159.0 4-Hydroxymethyl-4-methyl-l-phenyl-3-pyrazolidinone3.5 5.0 4.51 3.67 5-Methylbenzotriazole 0.12 0.12 0.151 0.119 Diethylene glycol20.0 20.0 20.0 20.0 Hydroquinone 39.0 32.0 34.2 51.3 Water to one liter pH at 25C 10.7 10.5 10.83 10.71 The above-described developing solutions were each employed at a temperature of 35C to develop a fore-hardened X-ray film as described in U. S. patent 4,414,304. Development was completed in 10.2 seconds in each of Examples 1 and 2, in 9.2 seconds in Example 3 and in 7.8 seconds in Example 4. The total processing cycle time was 45 seconds for Examples 1 and 2, 40 seconds for Example 3, and 35 8econds for Example 4. Measurements were made with respect to gross fog, film speed at a density of 1.0 above gross fog (l.OCR), mid scale contrast (MSC), lower scale contrast (LSC), upper scale contrast (USC~, and upper density point (UDP) and were found, in each case, to be acceptably similar to those obtained in the standard KODAK RP X-OMATTM proce~s. Each of the developing solutions was capable of being formulated ~ 2026606 and packaged as a single-part composition which exhibited acceptable shelf life and stability.
Example 5 In thiæ Example the sensitometric per~ormance obtained using the processing of Example 2 and three controls 2-A, 2-B and 2-C, differing from the Example 2 solely by the level of HMMP present, were compared with the sensitometric performance of a radiographic product intended to be processed in an aldehydic developer, such as a Kodak RP X-OmatTM 90 second process. Specifically, in Table II below the RP
X-Omat performance indicates the performance of a radiographic element of the type described in U.S.
Patent 4,900,652 processed in the following cycle:
development 24 sec. 35C
fixing 20 sec. 35C
washing 10 sec. 35C
drying 20 sec. 65C
Total processing time being 90 seconds, with time not otherwise accounted for being used in film transport.
The developer exhibited the following composition:
Hydroquinone 22 g l-Phenyl-3-pyrazolidone 1.35 g KOH 19.23 g NaHCO3 5.81 g K2S03 75 g NaBr 3.5 g 5-Methylbenzotriazole 0.06 g Glutaraldehyde 4.44 g 30, Water to 1 liter at pH 10.1 In addition another developer having a still higher HMMP level than that of Example 2 was compared. This developer, referred to the Example 5 developer, had the following composition:
Eydroquinone 32 g ~MMP 6 g KOH 24.4 g 5 NaHC03 7.5 g 2S3 75 g NaBr 2.25 g 5-Methylbenzotriazole 0.12 Water to 1 liter at pE 10.35.
A radiographic element identical to that employed in Example 2 was processed in the Example 5 developer using the following 45 æecond process cycle:
development 10.2 sec. 35C
fixing 8.7 sec. 35OC
washing 7.2 sec. 35C
drying 17.0 sec. 65C
Time not otherwise accounted for was consumed in film transport.
The results are compared below in Table II.
Table II ~`
Concentration ~ -Test of HMMP Gross Film (eramslliter) EQ~ Speed MSC LSC _~S UDP
2-A (Gomp.) 0.5 0.20 416 3.20 2.26 2.70 3.70 - :
2-B (Comp.) 1.0 0.20 424 3.24 2.20 3.05 3.75 25 2-C (Comp.) 3.0 0.21 433 2.94 2.09 2.66 3.59 Ex. 2 5.0 0.21 437 2.81 2.02 2.60 3.57 RP X-Omat 1.5* 0.20 438 2.89 2.00 3.34 3.65 Ex;. 5 6.0 0.22 439 2.91 2.05 3.07 3.70 *l-Phenyl-3-pryazolidone The data reported in Table II indicate that the developers of Examples 2 and 5 produced ; sensitometric resultæ cloæely approximating those obtained with the RP X-Omat 90 second procesæ in terms of speed, lower æcale contrast (LSC) and middle scale contrast (MSC). Theæe æenæitometric parameteræ affect the lower denæity image regions to which the eye is particularly senæitive. While some divergence in '.!,~,3, ~
~ 202~606 upper scale contrast (USC) and upper density point ~UDP) were observed, the eye is much less sensitive to variances in upper density image regions; therefore, these variances were deemed acceptable.
Comparing the performance of Controls 2-A, 2-B and 2-C, it can be seen that lower levels of EMMP
in these developers resulted in relatively poor matches in speed, MSC and LSC. Specifically, speeds were lower than those produced by RP X-Omat 90 second process and lower and middle scale contrasts were both elevated, indicating the importance of employing higher levels of ~MMP in the aldehydic hardener free developers of the invention.
The invention has been described in detail with particular reference to preferred embodiments thereof, but it will be understood that variations and modifications can be effected within the spirit and scope of the invention.
~ ~`
' ~' ~ -
Claims (10)
1. An aqueous alkaline photographic developing solution especially adapted for use in the development of fore-hardened X-ray films, said developing solution having a pH in the range of 9 to 12, being substantially free of both aldehydic hardening agents and silver halide solvents and comprising a dihydroxybenzene developing agent, an auxiliary super-additive developing agent, an alkaline agent, an organic anti-foggant and a preservative;
characterized in that said super-additive auxiliary developing agent is present in 2 concentration of at least 3.5 grams per liter of said developing solution and is a 4,4-disubstituted-1-aryl-3-pyrazolidinone of the formula:
wherein R1 and R2 are the same or different and each is alkyl of 1 to 6 carbon atoms or hydroxyalkyl of 1 to 6 carbon atoms, and R3 is hydrogen, halogen, alkyl of 1 to 6 carbon atoms or alkoxy of 1 to 6 carbon atoms.
characterized in that said super-additive auxiliary developing agent is present in 2 concentration of at least 3.5 grams per liter of said developing solution and is a 4,4-disubstituted-1-aryl-3-pyrazolidinone of the formula:
wherein R1 and R2 are the same or different and each is alkyl of 1 to 6 carbon atoms or hydroxyalkyl of 1 to 6 carbon atoms, and R3 is hydrogen, halogen, alkyl of 1 to 6 carbon atoms or alkoxy of 1 to 6 carbon atoms.
2. The developing solution as claimed in claim 1 wherein said dihydroxybenzene developing agent is hydroquinone.
3. The developing solution as claimed in claim 1 wherein said 4,4-disubstituted-1-aryl-3-pyrazolidinone is 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone.
4. The developing solution as claimed in claim 1 wherein said organic antifoggant is
5-methylbenzotriazole.
5. The developing solution as claimed in claim 1 wherein the amount of said 4,4-disubstituted-1-aryl-3-pyrazolidinone is from 3.5 to 10 grams per liter of said developing solution.
5. The developing solution as claimed in claim 1 wherein the amount of said 4,4-disubstituted-1-aryl-3-pyrazolidinone is from 3.5 to 10 grams per liter of said developing solution.
6. An aqueous alkaline photographic developing solution especially adapted for use in the development of fore-hardened X-ray films, said developing solution being substantially free of both aldehydic hardening agents and silver halide solvents and comprising from about 20 to about 60 grams per liter of hydroquinone, from 3.5 to 10 grams per liter of 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidin-one, an effective amount of an alkaline agent sufficient to provide a pH in the range of from 9 to 12, an effective amount of an organic antifoggant, and an effective amount of a preservative.
7. An aqueous alkaline photographic developing solution especially adapted for use in the development of fore-hardened X-ray films, said developing solution consisting essentially of 25 to 50 grams per liter of hydroquinone, 4 to 8 grams per liter of 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone, 5 to 10 grams per liter of sodium bicarbonate, 20 to 40 grams per liter of potassium hydroxide, 0.1 to 0.3 grams per liter of 5-methyl-benzotriazole, 50 to 80 grams per liter of potassium sulfite, 5 to 10 grams per liter of sodium metabisulfite, 1 to 4 grams per liter of sodium bromide, 10 to 30 grams per liter of diethylene glycol and 2 to 4 grams per liter of diethylenetriaminepenta-acetic acid.
8. A method of processing a fore-hardened X-ray film, said method comprising the step of developing said film by contacting it with an aqueous alkaline photographic developing solution especially adapted for use in the development of fore-hardened X-ray films, said developing solution having a pH in the range of 9 to 12, being substantially free of both aldehydic hardening agents and silver halide solvents and comprising a dihydroxybenzene developing agent, an auxiliary super-additive developing agent, an alkaline agent, an organic anti-foggant and a preservative, and said developing solution being characterized in that said super-additive auxiliary developing agent is present in a concentration of at least 3.5 grams per liter of said developing solution and is a 4,4-disubstituted-1-aryl-3-pyrazolidinone of the formula:
wherein R1 and R2 are the same or different and each is alkyl of 1 to 6 carbon atoms or hydroxyalkyl of 1 to 6 carbon atoms, and R3 is hydrogen, halogen, alkyl of 1 to 6 carbon atoms or alkoxy of 1 to 6 carbon atoms.
wherein R1 and R2 are the same or different and each is alkyl of 1 to 6 carbon atoms or hydroxyalkyl of 1 to 6 carbon atoms, and R3 is hydrogen, halogen, alkyl of 1 to 6 carbon atoms or alkoxy of 1 to 6 carbon atoms.
9. The method of claim 8 wherein said dihydroxybenzene developing agent is hydroquinone, said auxiliary super-additive developing agent is 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidinone and said organic antifoggant is 5-methylbenzotriazole.
10. The method of claim 9 wherein the amount of said 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazoli-dinone is from 4 to 8 grams per liter of said developing solution.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43530789A | 1989-11-13 | 1989-11-13 | |
US435,307 | 1989-11-13 | ||
US53766890A | 1990-06-14 | 1990-06-14 | |
US537,668 | 1990-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2026606A1 true CA2026606A1 (en) | 1991-05-14 |
Family
ID=27030513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2026606 Abandoned CA2026606A1 (en) | 1989-11-13 | 1990-10-01 | Photographic developing solution for use with fore-hardened x-ray films |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0428455A3 (en) |
JP (1) | JPH03161744A (en) |
CA (1) | CA2026606A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0542354B1 (en) * | 1991-11-14 | 2002-05-29 | Agfa-Gevaert | Method of developing x-ray materials |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE530884A (en) * | 1953-08-03 | |||
GB1157617A (en) * | 1965-09-09 | 1969-07-09 | Kodak Ltd | Method of making 3-Pyrazolidones |
US4414304A (en) * | 1981-11-12 | 1983-11-08 | Eastman Kodak Company | Forehardened high aspect ratio silver halide photographic elements and processes for their use |
JPH0648371B2 (en) * | 1986-11-07 | 1994-06-22 | 富士写真フイルム株式会社 | Processing method of silver halide photographic light-sensitive material for X-ray |
JPH0778618B2 (en) * | 1987-12-22 | 1995-08-23 | 富士写真フイルム株式会社 | Silver halide photographic material |
-
1990
- 1990-10-01 CA CA 2026606 patent/CA2026606A1/en not_active Abandoned
- 1990-10-31 EP EP19900420470 patent/EP0428455A3/en not_active Withdrawn
- 1990-11-05 JP JP29734190A patent/JPH03161744A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0428455A3 (en) | 1991-07-17 |
EP0428455A2 (en) | 1991-05-22 |
JPH03161744A (en) | 1991-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4269929A (en) | High contrast development of photographic elements | |
EP0724193B1 (en) | Radiographic film developers containing ascorbic acid and thioether development accelerators | |
USH2048H1 (en) | Non-hydroquinone photographic developer composition with lith quality and its method of usage | |
CA2026606A1 (en) | Photographic developing solution for use with fore-hardened x-ray films | |
US5738979A (en) | Black-and-white development processing method with replenishment | |
US5389502A (en) | Hardening developer for silver halide photography and development method | |
US5147767A (en) | Gluconic acid-based developer composition | |
US5503966A (en) | Photographic developing compositions and use thereof in the processing of photographic elements | |
EP0726491B1 (en) | Photographic fixer composition with reduced sulphur dioxide emissions | |
EP0446457B1 (en) | Alkaline black-and-white photographic developer | |
EP0267264B1 (en) | High contrast development of photographic elements | |
EP0696759B1 (en) | Method for processing a silver halide photographic light-sensitive material | |
US5830626A (en) | Photographic developing composition containing anti-sludging agent and use thereof | |
EP0753793B1 (en) | Photographic silver halide developer composition | |
JP2588733B2 (en) | Developing method of silver halide photographic material | |
JP3177797B2 (en) | Method for developing black-and-white silver halide photographic materials | |
JPH0555026B2 (en) | ||
JPH11143028A (en) | Solid developer for black-and-white silver halide photographic sensitive material | |
JPS63159846A (en) | Developer kit for photographic sensitive material having improved preservable property | |
EP1191395A1 (en) | Ascorbic acid developing compositions and methods of use | |
JPH0713285A (en) | Silver halide photographic sensitive material | |
JPH07119969B2 (en) | Development agent kit for silver halide photosensitive materials | |
JP2005010586A (en) | One-part concentrated developing solution for silver halide photographic sensitive material | |
JPH09304894A (en) | Concentrated development processing agent for silver halide photographic light-sensitive materials | |
JP2002156732A (en) | Processing method for silver halide photographic sensitive material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |